@vascern.bsky.social
Advancing the diagnosis, treatment, and care of patients with rare multisystemic vascular diseases across Europe. 🔬 Evidence-based guidelines | 🌍 Cross-border collaboration | 📚 Education 📌 Visit us: www.vascern.eu
The first EU report on the ERNs shows real progress:
📈 160% increase in new patients referred to ERN centres
🌍 1,600+ expert units connected across Europe
💻 2,100+ virtual consults improving access to specialist care
Read more: vascern.eu/news/ern-mon...
#rarediseases
🧠 Join our ESO–VASCERN webinar on practical tools and registries supporting care for CADASIL & Moyamoya Angiopathy with Dominique Hervé & Nicola Rifino
📅 11 Dec | 16:00 CET
🔗 Register: us02web.zoom.us/webinar/regi...
#Neurovascular #RareDisease #CADASIL #Moyamoya #MedEd
🩺 🥼 How does integrating the #ERNs into National Healthcare Systems support healthcare professionals?
By engaging with ERNs, they can:
💡 Access virtual consultations
🎓 Join continuous training
📊 Contribute to research, guidelines & registries
🤝 Enhance care coordination & collaboration
Is a clearer way to understand CADASIL? The new NOTCH3-SVD staging system outlines nine stages based on MRI + clinical features.
Our NEUROVASC group helped turn it into an accessible explainer video.
🎥 Watch more here: youtu.be/T5hgroNM7zo?...
#CADASIL #NOTCH3 #RareDisease
Not every conversation in care is easy especially when the diagnosis is rare.
This new toolkit, co-created by patients, psychologist and clinicians in VASCERN, offers real tools for better, more human #healthcommunication.
Access the toolkit ➡️ vascern.eu/news/rare-di...
#rarediseases
Missed the deadline? You have another chance to apply!
Applications for the VASCERN Summer School 2026 now close Nov 11.
Apply today → vascern.eu/training-and...
#VASCERNSummerSchool #RareDiseases
Textbooks teach theory. Our summer school brings it to life, connecting experts and patients with students eager to learn about rare vascular diseases.
Applications are open until Oct 27 → vascern.eu/training-and...
#VASCERNSummerSchool #RareDiseases #marfan #ehlersdanlos #lymphoedema
VASCERN Days 2025 kicks off in Paris 🎉
Morning sessions covered coordination, communication, CPMS 2.0, ERASMUS+ training, and new rules and extension.
Now on to the Transversal WG talks on Pregnancy, Registries, and Psychology.
#VASCERNDays2025
Big week ahead! Our annual VASCERN Days 2025 kicks off in Paris this Thursday and Friday.
Looking forward to seeing so many of our clinicians, ePAGs, and partners as we keep pushing forward together. 🫶
#VASCERNDays2025 #RareDisease #ERNs #CrossBorderCare
Yesterday we joined FAVA-Multi at Bichat Hospital to share who we are and raise awareness of rare vascular diseases.
Raising awareness is not limited to rare disease day, it happens all year, especially within the healthcare system where patients are treated.
The VASCERN Summer School 2025 may be over, but the lessons stay with our participants. For Elis, a medical student from Estonia, the highlight was an interactive CADASIL session that offered real clinical insight.
📢 Applications for the 2026 edition are open until October 27, 2025 👉 bit.ly/42MKOMT
✨ Last day at the #VASCERN Summer School 2025: no slides, no case discussions — just role plays, reflections, and practice in what matters most for patient care: communication.
📢 Apply now for 2026 👉 vascern.eu/training-and...
Day 1 of the #VASCERN Summer School 2025 wrapped up
🔹 HTAD: genetics, diagnosis, treatment, daily life & patient perspectives
🔹 MSA: Vascular EDS & arterial dissection
Talks, case discussions, coffee breaks and a networking event to come 🌍
#RareDiseases #MedicalEducation
🙌 It begins! #VASCERN Summer School 2025 kicks off today in Paris.
From packing goodies to welcoming a new cohort, the week ahead is all about rare vascular diseases, learning, and connection 💡
👉 Applications are now open for the 2026 cohort: vascern.eu/training-and...
From patient involvement to cross-border collaboration, this is how we make rare care stronger.
💾 Save this for later, 🔁 share it with your network, and explore more at www.vascern.eu
#rarediseases
VASCERN = Europe’s Reference Network for rare vascular diseases
But what does that actually mean?
Here are 5 facts about who we are, why we exist & how we work.
Swipe through the images ⬇️
☀️We're pressing pause for the summer. We're taking a short break from social media until September with fresh updates, resources, and news from our network.
Take this time to catch up on our resources at vascern.eu/resources/
Wishing you a restful and healthy #summerbreak!
Last Friday, our Neurovascular Diseases WG met in Essen 🇩🇪 for a collaborative summer meeting!
Key moments:
✅ Moyamoya e-learning module validated 🎉
✅ Scientific session + hands-on workshop
✅ Case discussions
Thanks to our hosts & all attendees!
#RareDiseases #CADASIL #Moyamoya #CrossBorderCare
A full day in Brussels led to big progress.
Our PPL group finalised
✔️ Clinical Outcome Measures Document (children & adults)
✔️ Do’s & Don’ts factsheets updated
✔️ Key issues discussed: compression in infants, surgery, transition, and more
📝 New resources coming soon!
#Lymphoedema #RareDisease
Happening today at 17:00 CEST!
Join Prof. Hugues Chabriat for a live webinar on #CADASIL — a rare #neurological disease often misdiagnosed. Learn how to spot key clinical signs & improve #diagnosis.
🎯 For #Neurology & stroke HCPs
👉 Register: bit.ly/4dMtprX
A graphic titled “Not Just a Nosebleed” highlights Hereditary Haemorrhagic Telangiectasia (HHT), a rare vascular disease that affects 1 in 5,000 people worldwide. The word “nosebleed” features a red blood droplet as the letter “O”. On the left, an icon shows 1 in 2 people living with HHT have AVMs in their lungs or liver. On the right, an icon shows 1 in 5 people living with HHT may have gastrointestinal bleeding. The graphic includes the logos of the European Reference Network, VASCERN, and the European Union, along with the date “HHT Awareness Day – June 23”.
Today is World HHT Day 🩸
HHT is a rare disease that affects 1 in 5,000 people. It can cause nosebleeds, internal bleeding, and serious health issues if left undiagnosed.
We’ve created simple, helpful tools to download and share: bit.ly/4liqauL
#WorldHHTDay #RareDisease #SeeBeyond
🚨 Only 4 days to go! Could that “MS” diagnosis actually be #CADASIL?
Join Prof. Chabriat to explore how MRI clues, progression, & family history can support accurate diagnosis.
🗓️ 23 June | 17:00 CEST
🔗 Register: ec.europa.eu/eusurvey/run...
#Neurology #RareDiseases #Webinar
🧠 #CADASIL is the most common genetic small vessel disease, first identified 40+ years ago. Still no treatment. Still under-recognised.
Join Prof. Hugues Chabriat for a webinar on its clinical spectrum.
📅 23 June | 🕔 17:00 CEST
Register here: bit.ly/4dMtprX
#CADASIL #RareDiseases #Stroke #Neurology
🔔 Join us on 23 June at 17:00 CEST for the launch of the #Together4RD Toolkit – a key resource to boost ERN-industry collaboration in #RareDisease research.
🔹 Practical tools
🔹 Real-world cases
🔹 Expert speakers
👉 Register: loom.ly/9TZyyX4
#ERDERA
🗣️“Even though a cure doesn’t exist, I believe one day HHT will be a disease to remember not one to fear.”
At the recent Based on Evidence #European meeting, experts came together to share evidence-based ways to improve #HHT care across #Europe.
Read more ➡️ bit.ly/3HmPMbr
🩸 Our HHT Working Group just wrapped up its Spring Meeting!
Key highlights from the day:
🔹 Clinical case discussions
🔹 Do’s & Don’ts for #pregnancy in HHT
🔹 Registry updates
🔹 #Ultrasound course in development
🔹 Preparation for next BEE Meeting
Thank you to all who participated!
📢 New resource alert! A gene compendia summarising key genes involved in heritable thoracic aortic diseases like #Marfan & #LoeysDietz syndromes.
For #geneticists, #cardiologists, #researchers & more.
Explore it here ➡️ bit.ly/4kp2YL5
#RareDiseases #Genetics
🔴 Today is REDS4VEDS Day 2025, marking 10 years of awareness for vascular Ehlers-Danlos syndrome (vEDS).
Many are still diagnosed only after a medical emergency. We’ve created tools to support vEDS care.
Watch: youtu.be/j6XQJIicJCU?...
More info: bit.ly/4kmcvlV
#REDS4VEDS #vEDS #EDS #RareDisease
Up to 75% of people with Moyamoya angiopathy suffer from disabling headaches often without proper diagnosis or care.
Our recent webinar on #headache in Moyamoya shares crucial insights on diagnosis & treatment.
🎥Watch here: bit.ly/3S0tCOo
#Moyamoya #RareDiseases
If you are interested in the clinical aspects of lymphatic diseases, don't miss the 30th ISL World Congress of Lymphology. #lymph @vascern.bsky.social
#issva #theralymph
